Skip to main content

Elevating Equity in Caring for Patients with Hematologic Malignancies

Recorded on: December 9, 2022

Click Here to Participate 

Recorded on: December 9, 2022
Estimated Time: 1.0 hour
CME & CE Activity Release Date: December 29, 2022
CME & CE Credit Valid Through: December 29, 2023 
1.0 CME/CE Credit/Contact Hour for physicians and registered nurses. 


Target Audience

This activity is intended for hematology/oncology specialists, nurses and nurse practitioners, including those specializing in hematology/oncology.



A multidisciplinary panel consisting of a hematologist/oncologist, nurse practitioner (NP), and patient advocate will provide a comprehensive review of specific issues that affect patients with hematologic malignancies, including guidance for community practice, clinical strategies to address disparities, healthcare policies, and patient access considerations. The goal of this activity is that learners will be better able to recognize healthcare disparities and their multifactorial etiologies, and implement strategies and identify resources that proactively address barriers associated with disparities in care and health outcomes.


Learning Objectives

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the health disparities in hematologic malignancies
  • Have greater competence related to strategies that may be used to address barriers to optimal care and outcomes in diverse patient populations with hematologic malignancies
  • Demonstrate greater confidence in their ability to provide interprofessional care for racially and ethnically diverse patients with hematologic malignancies


Adrienne A. Phillips, MD, MPH (moderator)
Associate Professor of Clinical Medicine
Division of Hematology/Medical Oncology
Weill Cornell Medical College
Associate Attending
Weill Cornell Medical Center
New York, New York

Laura Ortiz-Ravick, MA (panelist)
Outreach and Health Promotion
The Leukemia & Lymphoma Society
Rye Brook, New York

Amber Thomassen, APRN-BC, AOCNP (panelist)
Clinical Operations APP Team Manager
Sylvester Comprehensive Cancer Center
University of Miami
Miami, Florida


Continuing Education Information 

Accreditation Statement Logos

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Interprofessional Continuing Education (IPCE) credit

This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.

ABIM CME MOC Accredited

For Physicians
Medscape, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.


For Nurses
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.

There are no fees for participating in or receiving credit for this CE activity.

This activity is developed through a collaboration between The Leukemia & Lymphoma Society and Medscape Oncology.

This activity is supported by an independent educational grant from AstraZeneca; Bristol Myers Squibb; Genentech; Gilead Sciences Inc.; GlaxoSmithKline; Legend Biotech; Lilly; Pharmacyclics LLC, An AbbVie Company and Janssen Biotech Inc.; and Regeneron Pharmaceuticals.


Click Here to Participate 

Participants gain access to the webinar via the registration button above.

For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at



< Back to Continuing Education